Ethyl 1-Methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylate

ID: ALA4745419

PubChem CID: 162648067

Max Phase: Preclinical

Molecular Formula: C14H16N2O3

Molecular Weight: 260.29

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1c(C)nc(-c2ccccc2)n1OC

Standard InChI:  InChI=1S/C14H16N2O3/c1-4-19-14(17)12-10(2)15-13(16(12)18-3)11-8-6-5-7-9-11/h5-9H,4H2,1-3H3

Standard InChI Key:  DIRUIFJKUGRZMM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
   13.8496   -4.7999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8484   -5.6195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5565   -6.0284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2661   -5.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2633   -4.7963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5547   -4.3911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9672   -4.3867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7150   -4.7163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2595   -4.1069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8483   -3.4007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0496   -3.5737    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0726   -4.1893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4402   -3.0293    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.1778   -2.6529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9901   -2.5643    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.6949   -1.9936    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.3196   -1.8165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1320   -1.7280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6640   -3.2848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  1  0
  5  7  1  0
  9 12  1  0
 11 13  1  0
 10 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  1  0
 17 18  1  0
 13 19  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4745419

    ---

Associated Targets(non-human)

Plasma (649 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 260.29Molecular Weight (Monoisotopic): 260.1161AlogP: 2.09#Rotatable Bonds: 4
Polar Surface Area: 53.35Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.26CX LogP: 2.00CX LogD: 2.00
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.79Np Likeness Score: -0.89

References

1. Lei Y,Zhang B,Liu D,Zhao J,Dai X,Gao J,Mao Q,Feng Y,Zhao J,Lin F,Duan Y,Zhang Y,Bao Z,Yang Y,Mou Y,Wang S.  (2020)  Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y and P2Y as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor.,  63  (24): [PMID:33307675] [10.1021/acs.jmedchem.0c01524]

Source